Published in Biotechnol J on September 01, 2015
Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion. Front Microbiol (2016) 0.80
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems. Int J Mol Sci (2016) 0.80
Environmentally controlled bacterial vesicle-mediated export. Cell Microbiol (2016) 0.78
Cell membrane-derived nanomaterials for biomedical applications. Biomaterials (2017) 0.76
Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs. Appl Microbiol Biotechnol (2016) 0.75
Membrane Vesicles Released by a hypervesiculating Escherichia coli Nissle 1917 tolR Mutant Are Highly Heterogeneous and Show Reduced Capacity for Epithelial Cell Interaction and Entry. PLoS One (2016) 0.75
The druggable genome. Nat Rev Drug Discov (2002) 13.61
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 6.55
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet (1991) 6.26
Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol (1999) 5.66
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science (2007) 4.90
Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med (1973) 4.32
Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev (2005) 4.14
Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol (2010) 4.13
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol (2010) 4.06
Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell (2003) 3.88
Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol (1995) 3.73
Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins. J Bacteriol (1978) 3.57
Relation between excreted lipopolysaccharide complexes and surface structures of a lysine-limited culture of Escherichia coli. J Bacteriol (1966) 3.36
Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann (1991) 3.32
Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev (2010) 3.27
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest (1996) 2.94
Membrane vesicles: an overlooked component of the matrices of biofilms. J Bacteriol (2006) 2.89
Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J Bacteriol (1989) 2.83
Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol (2006) 2.79
Murein (peptidoglycan) structure, architecture and biosynthesis in Escherichia coli. Biochim Biophys Acta (2007) 2.72
Special delivery: vesicle trafficking in prokaryotes. Mol Microbiol (2006) 2.63
Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J Biol Chem (2000) 2.63
Proteomic analysis of the Escherichia coli outer membrane. Eur J Biochem (2000) 2.59
Release of outer membrane fragments from normally growing Escherichia coli. Biochim Biophys Acta (1976) 2.51
Escherichia coli tol-pal mutants form outer membrane vesicles. J Bacteriol (1998) 2.48
Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun (2004) 2.44
Reverse vaccinology. Curr Opin Microbiol (2000) 2.36
Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun (2001) 2.16
DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential. Microbiology (2004) 2.06
Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J Bacteriol (2006) 2.01
Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease. Infect Immun (2011) 1.99
Bacteriolytic effect of membrane vesicles from Pseudomonas aeruginosa on other bacteria including pathogens: conceptually new antibiotics. J Bacteriol (1996) 1.96
Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics (2007) 1.95
Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release. J Antimicrob Chemother (1997) 1.91
Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics (2009) 1.89
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine (2009) 1.88
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol (2009) 1.87
A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol (2008) 1.83
Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest (2011) 1.80
Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem (2003) 1.76
Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines (2007) 1.76
Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev (2008) 1.74
Lipoproteins of bacterial pathogens. Infect Immun (2010) 1.73
Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun (2012) 1.73
Biogenesis of bacterial membrane vesicles. Mol Microbiol (2009) 1.69
Preferential release of new outer membrane fragments by exponentially growing Escherichia coli. Biochim Biophys Acta (1978) 1.69
Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl Environ Microbiol (2000) 1.67
Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc Natl Acad Sci U S A (2010) 1.62
Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol (2007) 1.57
Interaction of quorum signals with outer membrane lipids: insights into prokaryotic membrane vesicle formation. Mol Microbiol (2008) 1.56
Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine (1996) 1.54
Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun (2008) 1.50
Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. J Gen Microbiol (1967) 1.49
Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol (2011) 1.48
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis (2009) 1.47
Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun (1992) 1.44
Selective sorting of cargo proteins into bacterial membrane vesicles. J Biol Chem (2010) 1.44
Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J Biol Chem (2005) 1.39
Outer-membrane vesicles released by normally growing Escherichia coli contain very little lipoprotein. Eur J Biochem (1981) 1.39
Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics (2006) 1.39
The flat-ribbon configuration of the periplasmic flagella of Borrelia burgdorferi and its relationship to motility and morphology. J Bacteriol (2008) 1.39
DNA Is Packaged within Membrane-Derived Vesicles of Gram-Negative but Not Gram-Positive Bacteria. Appl Environ Microbiol (1990) 1.39
A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol Lett (2000) 1.38
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc Natl Acad Sci U S A (2014) 1.36
Proteomic analysis of secreted membrane vesicles of archaeal Sulfolobus species reveals the presence of endosome sorting complex components. Extremophiles (2008) 1.34
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine (2000) 1.31
Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect Immun (2010) 1.30
Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. Mol Cell Proteomics (2007) 1.30
A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine (2011) 1.27
Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine (1996) 1.27
Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect Immun (2008) 1.24
Structural vaccinology starts to deliver. Nat Rev Microbiol (2012) 1.22
Heat-induced blebbing and vesiculation of the outer membrane of Escherichia coli. J Bacteriol (1982) 1.21
A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs (2014) 1.20
Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni. BMC Microbiol (2009) 1.19
Biochemical and functional characterization of Helicobacter pylori vesicles. Mol Microbiol (2010) 1.18
Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun (1999) 1.17
Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa. Proteomics (2011) 1.17
Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine (2011) 1.17
Bacterial outer membrane vesicles and vaccine applications. Front Immunol (2014) 1.16
Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. MBio (2014) 1.13
High yield production process for Shigella outer membrane particles. PLoS One (2012) 1.12
Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun (2010) 1.12
Porphyromonas gingivalis outer membrane vesicles exclusively contain outer membrane and periplasmic proteins and carry a cargo enriched with virulence factors. J Proteome Res (2014) 1.12
Envelope control of outer membrane vesicle production in Gram-negative bacteria. Biochemistry (2013) 1.11
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother (2013) 1.10
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine (2010) 1.09
Cholesterol lipids of Borrelia burgdorferi form lipid rafts and are required for the bactericidal activity of a complement-independent antibody. Cell Host Microbe (2010) 1.09
Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function. Cell Microbiol (2006) 1.08
Release of a special fraction of the outer membrane from both growing and phage T4-infected Escherichia coli B. Biochim Biophys Acta (1978) 1.08
Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine. J Proteome Res (2011) 1.07
Elicitation of epithelial cell-derived immune effectors by outer membrane vesicles of nontypeable Haemophilus influenzae. Infect Immun (2011) 1.07
Three-dimensional macromolecular organization of cryofixed Myxococcus xanthus biofilms as revealed by electron microscopic tomography. J Bacteriol (2009) 1.07
Principles of vaccine design-Lessons from nature. Vaccine (2010) 1.06
A bilayer-couple model of bacterial outer membrane vesicle biogenesis. MBio (2012) 1.05
The interaction of naturally elaborated blebs from serum-susceptible and serum-resistant strains of Neisseria gonorrhoeae with normal human serum. Mol Microbiol (1992) 1.05
Preferential packing of acidic glycosidases and proteases into Bacteroides outer membrane vesicles. MBio (2014) 1.05